Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - OTHER CURRENT ASSETS
Other Current Assets ALNY - Alnylam Pharmaceuticals, Inc.
117 M
LAST VALUE
-6.19%
2 YEAR CAGR
7.80%
5 YEAR CAGR
19.63%
10 YEAR CAGR